Investigating Novel Functions for NIK/MAP3K14 in High-Grade Glioma

研究 NIK/MAP3K14 在高级别胶质瘤中的新功能

基本信息

项目摘要

PROJECT SUMMARY Cancer cells are able to adapt to grow uncontrollably and invasively in environments with limited availability of nutrients — most notably, glucose and oxygen. Indeed, the aggressive migration and invasion of high- grade gliomas, including glioblastoma multiforme (GBM), into healthy brain tissue are major factors contributing to the therapy resistance and poor prognosis of this malignancy. While many cancer cells preferentially utilize glycolysis to support growth, GBM cells have been shown to rely on both glycolysis and mitochondrial metabolism for glucose energy utilization. Mitochondrial dynamics, or the balance between mitochondrial fission and fusion, is a central mechanism for bioenergetic adaptations to cellular stresses such as nutrient deprvation. Therefore, targeting de-regulated mitochondrial function is a highly attractive therapeutic strategy for GBM. Recent findings have established key roles for NF-κB-inducing kinase (NIK/MAP3K14) in regulating mitochondrial dynamics and subcellular trafficking to promote the invasiveness and pathogenesis of GBM cells. Moreover, preliminary data demonstrate that mitochondrial NIK enhances the resistance of GBM cells to nutrient/glucose starvation through regulation of mitochondrial metabolism. Moreover, the mitochondrial actions of NIK are independent of its regulation of NF-κB activity. However, the molecular mechanisms by which NIK coordinates regulation of mitochondrial function and metabolic reprogramming in GBM cells are currently not known. This proposal tests the hypothesis that NIK is induced by, and is an important regulator of, mitochondrial dynamics, cancer cell metabolism and infiltrative growth in response to nutrient deprivation. The goals of the proposal are to functionally define NIK-dependent regulatory networks and metabolic pathways that regulate cancer cell mitochondrial functions and test the whether NIK inhibition will sensitize GBM cells to nutrient starvation and attenuate tumor cell survival and pathogenesis. This proposal is anticipated to have an important positive impact because understanding the molecular basis of NIK mitochondrial functions is likely to generate strong justification for the development of novel, mechanism-based therapies for GBM that target mitochondrial dysfunction, invasion, and de-regulated metabolism through NIK inhibition with the ultimate goal of improving patient survival. !
项目摘要 癌细胞能够适应在有限的环境中不受控制地和侵入性地生长 营养物质--最显著的是葡萄糖和氧气。事实上,高海拔地区的侵略性迁移和入侵- 包括多形性胶质母细胞瘤(GBM)在内的分级胶质瘤进入健康脑组织是主要因素 导致这种恶性肿瘤的治疗抗性和不良预后。虽然许多癌细胞 尽管GBM细胞优先利用糖酵解来支持生长,但已经显示GBM细胞依赖于糖酵解和糖代谢两者, 线粒体代谢葡萄糖能量利用。线粒体动力学,或者说 线粒体的分裂和融合是生物能量适应细胞应激的中心机制 例如营养缺乏。因此,靶向失调的线粒体功能是一种非常有吸引力的方法。 GBM的治疗策略最近的研究结果表明,NF-κ B诱导激酶 (NIK/MAP 3 K14)在调节线粒体动力学和亚细胞运输以促进细胞增殖中的作用。 GBM细胞的侵袭性和发病机制。此外,初步数据表明, NIK通过调节线粒体膜电位增强GBM细胞对营养/葡萄糖饥饿的抵抗力 新陈代谢.此外,NIK的线粒体作用不依赖于其对NF-κB活性的调节。 然而,NIK协调线粒体功能调节的分子机制, GBM细胞中的代谢重编程目前尚不清楚。这一提议检验了NIK的假设, 是由线粒体动力学、癌细胞代谢和细胞周期的重要调节因子, 营养缺乏导致的渗透性生长。该提案的目标是从功能上定义 调节癌细胞线粒体的NIK依赖性调节网络和代谢途径 功能,并测试NIK抑制是否会使GBM细胞对营养饥饿敏感, 肿瘤细胞存活和发病机制。预计这一提议将产生重要的积极影响 因为了解NIK线粒体功能的分子基础可能会产生强大的 开发靶向线粒体的新型、基于机制的GBM疗法的理由 通过NIK抑制功能障碍、侵袭和代谢失调,最终目标是 提高患者生存率。 !

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Transcriptional induction of NF-κB-inducing kinase by E2F4/5 facilitates collective invasion of GBM cells.
  • DOI:
    10.1038/s41598-023-38996-9
  • 发表时间:
    2023-08-11
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Pflug, Kathryn M.;Lee, Dong W.;McFadden, Kassandra;Herrera, Linda;Sitcheran, Raquel
  • 通讯作者:
    Sitcheran, Raquel
Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer.
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
  • DOI:
    10.1186/s12943-014-0273-1
  • 发表时间:
    2015-01-27
  • 期刊:
  • 影响因子:
    37.3
  • 作者:
    Cherry EM;Lee DW;Jung JU;Sitcheran R
  • 通讯作者:
    Sitcheran R
NIK promotes metabolic adaptation of glioblastoma cells to bioenergetic stress.
  • DOI:
    10.1038/s41419-020-03383-z
  • 发表时间:
    2021-03-15
  • 期刊:
  • 影响因子:
    9
  • 作者:
    Kamradt ML;Jung JU;Pflug KM;Lee DW;Fanniel V;Sitcheran R
  • 通讯作者:
    Sitcheran R
NF-κB-inducing kinase maintains mitochondrial efficiency and systemic metabolic homeostasis.
NF-κB 诱导激酶维持线粒体效率和全身代谢稳态。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAQUEL SITCHERAN其他文献

RAQUEL SITCHERAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAQUEL SITCHERAN', 18)}}的其他基金

Pathway-Specific NF-kappaB Regulatory Networks in Glioma
神经胶质瘤中通路特异性 NF-kappaB 调节网络
  • 批准号:
    9018069
  • 财政年份:
    2014
  • 资助金额:
    $ 32.48万
  • 项目类别:
Pathway-Specific NF-kappaB Regulatory Networks in Glioma
神经胶质瘤中通路特异性 NF-kappaB 调节网络
  • 批准号:
    8814285
  • 财政年份:
    2014
  • 资助金额:
    $ 32.48万
  • 项目类别:
Pathway-Specific NF-kappaB Regulatory Networks in Glioma
神经胶质瘤中通路特异性 NF-kappaB 调节网络
  • 批准号:
    8697269
  • 财政年份:
    2014
  • 资助金额:
    $ 32.48万
  • 项目类别:
NF-kappaB N-myc in Oncogenic Pathways of the CNS
中枢神经系统致癌途径中的 NF-kappaB N-myc
  • 批准号:
    7939233
  • 财政年份:
    2009
  • 资助金额:
    $ 32.48万
  • 项目类别:
NF-kappaB N-myc in Oncogenic Pathways of the CNS
中枢神经系统致癌途径中的 NF-kappaB N-myc
  • 批准号:
    7655366
  • 财政年份:
    2006
  • 资助金额:
    $ 32.48万
  • 项目类别:
NF-kappaB N-myc in Oncogenic Pathways of the CNS
中枢神经系统致癌途径中的 NF-kappaB N-myc
  • 批准号:
    7933859
  • 财政年份:
    2006
  • 资助金额:
    $ 32.48万
  • 项目类别:
NF-kappaB N-myc in Oncogenic Pathways of the CNS
中枢神经系统致癌途径中的 NF-kappaB N-myc
  • 批准号:
    7477942
  • 财政年份:
    2006
  • 资助金额:
    $ 32.48万
  • 项目类别:
NF-kappaB N-myc in Oncogenic Pathways of the CNS
中枢神经系统致癌途径中的 NF-kappaB N-myc
  • 批准号:
    7017578
  • 财政年份:
    2006
  • 资助金额:
    $ 32.48万
  • 项目类别:
NF-kappaB N-myc in Oncogenic Pathways of the CNS
中枢神经系统致癌途径中的 NF-kappaB N-myc
  • 批准号:
    7270635
  • 财政年份:
    2006
  • 资助金额:
    $ 32.48万
  • 项目类别:

相似海外基金

Bioenergetics in Health and Diseases
健康与疾病中的生物能量学
  • 批准号:
    10609120
  • 财政年份:
    2023
  • 资助金额:
    $ 32.48万
  • 项目类别:
Control of epithelial morphology and bioenergetics by Toll receptors during dynamic tissue remodeling
动态组织重塑过程中 Toll 受体对上皮形态和生物能的控制
  • 批准号:
    10737093
  • 财政年份:
    2023
  • 资助金额:
    $ 32.48万
  • 项目类别:
Mitochondria-rich microvesicles for restoration of intracellular bioenergetics
富含线粒体的微泡用于恢复细胞内生物能
  • 批准号:
    10586699
  • 财政年份:
    2023
  • 资助金额:
    $ 32.48万
  • 项目类别:
Defining the mechanisms of MSC extracellular vesicle modulation of microglia metabolism and bioenergetics in traumatic brain injury recovery
定义MSC细胞外囊泡调节小胶质细胞代谢和生物能学在创伤性脑损伤恢复中的机制
  • 批准号:
    10719905
  • 财政年份:
    2023
  • 资助金额:
    $ 32.48万
  • 项目类别:
Characterizing Alzheimer's Risk in Retired Night Shift Workers: Cognitive Function, Brain Volume, and Brain Bioenergetics
退休夜班工人患阿尔茨海默病的风险特征:认知功能、脑容量和脑生物能学
  • 批准号:
    10350125
  • 财政年份:
    2022
  • 资助金额:
    $ 32.48万
  • 项目类别:
To everything a season: bioenergetics in seasonal environments
季节的一切:季节性环境中的生物能学
  • 批准号:
    RGPIN-2020-06705
  • 财政年份:
    2022
  • 资助金额:
    $ 32.48万
  • 项目类别:
    Discovery Grants Program - Individual
The role of transcription factor Ying-Yang 1 in the cardiac bioenergetics regulation
转录因子Ying-Yang 1在心脏生物能调节中的作用
  • 批准号:
    10688160
  • 财政年份:
    2022
  • 资助金额:
    $ 32.48万
  • 项目类别:
Modulating Cellular Bioenergetics to Improve Skeletal Health
调节细胞生物能量以改善骨骼健康
  • 批准号:
    10661806
  • 财政年份:
    2022
  • 资助金额:
    $ 32.48万
  • 项目类别:
Unraveling the Associations of Molecular-Genetic Bioenergetics and Chemotherapy-Induced Fatigue Symptoms in Patients with Breast Cancer
揭示乳腺癌患者分子遗传学生物能学与化疗引起的疲劳症状之间的关联
  • 批准号:
    10684326
  • 财政年份:
    2022
  • 资助金额:
    $ 32.48万
  • 项目类别:
Bioenergetics and Neuronal Network Remodeling in a Rodent Model of Temporal Lobe Epilepsy
颞叶癫痫啮齿动物模型中的生物能量学和神经元网络重塑
  • 批准号:
    10373152
  • 财政年份:
    2022
  • 资助金额:
    $ 32.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了